A randomized phase 3 trial of intraperitoneal versus intravenous carboplatin with dose-dense weekly paclitaxel in patients with ovarian, fallopian tube, or primary peritoneal carcinoma (a GOTIC-001/JGOG-3019/GCIG, iPocc Trial) (LBA 3)

Autor:	Keiichi Fujiwara, Shoji Nagao, Kouji Yamamoto, Hiroshi Tanabe, Aikou Okamoto, Kazuhiro Takehara, MOTOAKI SAITO, Hiroyuki Fujiwara, David Tan, Sosuke Adachi, Satoshi Yamaguchi, Akira Kikuchi, Takeshi Hirasawa, Takeshi Yokoi, Tomonori Nagai, Toyomi Satoh, Shoji Kamiura, Akira Fujishita, Karen Chan, Peter Sykes, Alexander Olawaiye, Sang-Young Ryu, Wai Loong Wong, Takashi Matsumoto, Kosei Hasegawa, Takayuki Enomoto
Rok vydání:	2022
Předmět:	Oncology Obstetrics and Gynecology
Zdroj:	Gynecologic Oncology. 166:S49-S50
ISSN:	0090-8258
DOI:	10.1016/s0090-8258(22)01296-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2964e6b7942fd774ad8c8203fca59262 https://doi.org/10.1016/s0090-8258(22)01296-3 Zobrazit plný text záznamu Full Text from ScienceDirect